216 related articles for article (PubMed ID: 20181616)
21. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
22. Hsp90alpha recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells.
Hung JJ; Wu CY; Liao PC; Chang WC
J Biol Chem; 2005 Oct; 280(43):36283-92. PubMed ID: 16118214
[TBL] [Abstract][Full Text] [Related]
23. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models.
Pencovich N; Jaschek R; Tanay A; Groner Y
Blood; 2011 Jan; 117(1):e1-14. PubMed ID: 20959602
[TBL] [Abstract][Full Text] [Related]
24. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
Ajore R; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
[TBL] [Abstract][Full Text] [Related]
25. A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target gene.
Hug BA; Ahmed N; Robbins JA; Lazar MA
J Biol Chem; 2004 Jan; 279(2):825-30. PubMed ID: 14561740
[TBL] [Abstract][Full Text] [Related]
26. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
27. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation of human 12-lipoxygenase gene promoter is mediated through Sp1 consensus sites in A431 cells.
Liu YW; Arakawa T; Yamamoto S; Chang WC
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):133-40. PubMed ID: 9164849
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.
Bristow CA; Shore P
Nucleic Acids Res; 2003 Jun; 31(11):2735-44. PubMed ID: 12771199
[TBL] [Abstract][Full Text] [Related]
30. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX
Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
32. p63 directly induces expression of Alox12, a regulator of epidermal barrier formation.
Kim S; Choi IF; Quante JR; Zhang L; Roop DR; Koster MI
Exp Dermatol; 2009 Dec; 18(12):1016-21. PubMed ID: 19555433
[TBL] [Abstract][Full Text] [Related]
33. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor‑related apoptosis‑inducing ligand is a novel transcriptional target of runt‑related transcription factor 1.
Yoshida T; Yamasaki K; Tadagaki K; Kuwahara Y; Matsumoto A; Sofovic AE; Kondo N; Sakai T; Okuda T
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958111
[TBL] [Abstract][Full Text] [Related]
35. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
[TBL] [Abstract][Full Text] [Related]
36. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R
J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842
[TBL] [Abstract][Full Text] [Related]
37. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation.
Tornhamre S; Elmqvist A; Lindgren JA
Biochim Biophys Acta; 2000 Apr; 1484(2-3):298-306. PubMed ID: 10760478
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and expression of human arachidonate 12-lipoxygenase.
Yoshimoto T; Yamamoto Y; Arakawa T; Suzuki H; Yamamoto S; Yokoyama C; Tanabe T; Toh H
Biochem Biophys Res Commun; 1990 Nov; 172(3):1230-5. PubMed ID: 2244907
[TBL] [Abstract][Full Text] [Related]
39. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
[TBL] [Abstract][Full Text] [Related]
40. Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk.
Contursi A; Tacconelli S; Hofling U; Bruno A; Dovizio M; Ballerini P; Patrignani P
Biochem Pharmacol; 2022 Nov; 205():115252. PubMed ID: 36130648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
